Stockreport

Boehringer kickstarts two Phase III trials as MASH therapy wins breakthrough status [Yahoo! Finance]

Madrigal Pharmaceuticals, Inc.  (MDGL) 
Last madrigal pharmaceuticals, inc. earnings: 2/26 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: madrigalpharma.com
PDF Concurrently, the company also started two Phase III trials, LIVERAGE and LIVERAGE-Cirrhosis, evaluating the therapy in patients with MASH with associated moderate or a [Read more]